← All trials
NCT05177848
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 29, 2022
- Primary completion
- Mar 1, 2024
- Completion date
- Mar 1, 2024
- First posted
- Jan 5, 2022
- Last posted
- Jul 11, 2022
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Virginia Polytechnic Institute and State UniversityLead sponsor
- National Cancer Institute (NCI)Collaborator
- Virginia Polytechnic Institute and State UniversityOverall official - principal investigator
- Virginia Polytechnic Institute and State UniversityReponsible party - principal investigator
- Medical University of South CarolinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.